Anthem Biosciences Limited
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-07-22
Analyst
HDFC Securities Limited
Equibles does not estimate personal net worth.
Mayholzade is recorded as Analyst at HDFC Securities Limited. Mayholzade has spoken on 1 earnings call across 1 company, most recently for Anthem Biosciences Limited on July 22, 2026. The companies whose calls Mayholzade spoke on are classified in the Healthcare sector.
“So, first question is around like on your pipeline and late phase molecules. So, as of now, we have something like 800 plus kind of active projects plus 10 molecules are in late phase.”
HDFC Securities Limited
Analyst
Transcript header (unverified)
Anthem Biosciences Limited
Biotechnology · Healthcare
Earnings Call for the Quarter Ended June 30, 2026
Anthem Biosciences Limited